40
In band
Moving averages
SMA 200$22.64+33.70%
Company profile
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos, California.
SectorHealthcare
IndustryBiotechnology
Market cap$1.26B
P/E ratioNone
EPS$-2.32
Beta1.156
Dividend yield0.00%
52-week high$37.48
52-week low$3.59
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 44
VRTX
Vertex Pharmaceuticals Inc
RSI 41
CRSP
CRISPR Therapeutics AG
RSI 55
IOVA
Iovance Biotherapeutics Inc
RSI 76
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 62
MRNA
Moderna Inc
RSI 63
VKTX
Viking Therapeutics Inc
RSI 31
SRPT
Sarepta Therapeutics Inc
RSI 50
EDIT
Editas Medicine Inc
RSI 43
NVAX
Novavax Inc
RSI 62
RSI alerts for ANRO
Get an email the moment Alto Neuroscience, Inc. crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 12:20 PM EDT